Selected Grants
A prospective, multi-center, randomized, parallel-group, controlled study to evaluate the efficacy and safety of OTXTIC (travoprost) intracameral implant in subjects with open-angle glaucoma (OAG) or ocular hypertension (OHT)
Clinical TrialPrincipal Investigator · Awarded by Ocular Therapeutix Inc · 2022 - 2024Evaluating the use of a sustained-release intracanalicular dexamethasone insert (Dextenza, Ocular Therapeutix, Inc) in Minimally invasive glaucoma surgery (MIGS)
ResearchPrincipal Investigator · Awarded by Ocular Therapeutix Inc · 2021 - 2024Eyes of Africa: The Genetics of Blindness
ResearchSignificant Contributor · Awarded by University of Ibadan · 2017 - 2023Patient Preference, Efficacy, and Safety of an Intracanalicular Dexamenthasone Insert compared to Topical Prednisolone in Patients Undergoing Sequential Phacoemulsification with Intraocular Lens Surge
Clinical TrialPrincipal Investigator · Awarded by Ocular Therapeutix Inc · 2020 - 2021GTS100-PAR: GLAUKOS ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM IN CONJUNCTION WITH CATARACT SURGERY POSTMARKET REGISTRY
Clinical TrialPrincipal Investigator · Awarded by Glaukos Corporation · 2014 - 2019Genomic Convergence in Primary Open Angle Glaucoma
ResearchConsultant · Awarded by National Institutes of Health · 2004 - 2010Genetic Studies of POAG in Ghana, West Africa
ResearchInvestigator · Awarded by National Institutes of Health · 2003 - 2007External Relationships
- Alcon, Inc
- Allergan
- Balance Ophthalmics
- Glaukos Corporation
- New World Medical, Inc
- Ocular Therapeutix Inc.
- Sight Sciences
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.